Venrock

Activity from announced rounds

Activity in this selectionOct 22, 2026 · AI · Jan 1, 2026

Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.

Recorded funding activity

Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$159M
3 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Enterprise software1
Healthtech1
Logistics1

By country

United States3

Rounds

3 in this selection
Suki

Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.

$90MSeries E
Participant
Gitar

Builds AI agents for code review and continuous integration workflows

$9MUndisclosed
Role not disclosed
GenLogs

Provides a truck intelligence platform using roadside sensors and AI to secure freight networks

$60MSeries B
Role not disclosed